These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32454856)

  • 61. Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response.
    Chang QQ; Pan YF; Yang JY; Li RS; Yuan CL; Liao YF; Zhang DD; Liu CH
    Evid Based Complement Alternat Med; 2022; 2022():5752803. PubMed ID: 36411840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.
    Wang X; Wang Q; Burczynski FJ; Kong W; Gong Y
    Phytomedicine; 2013 Nov; 20(14):1330-5. PubMed ID: 23969230
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
    Park SY; Le CT; Sung KY; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail.
    Song YN; Sun JJ; Lu YY; Xu LM; Gao YQ; Zhang W; Wang XS; Xue DY; Zheng QS; Su SB
    Evid Based Complement Alternat Med; 2013; 2013():709305. PubMed ID: 23533516
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.
    Wang X; Ai L; Xu Q; Wu C; Chen Z; Su D; Jiang X; Fan Z
    Inflammation; 2017 Jun; 40(3):840-848. PubMed ID: 28251449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.
    Song YN; Chen J; Cai FF; Lu YY; Chen QL; Zhang YY; Liu P; Su SB
    Acta Pharmacol Sin; 2018 Jun; 39(6):942-951. PubMed ID: 29072258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetic study of five components of Fuzheng Huayu tablets in healthy human plasma.
    Zhang H; Hu Y; Liu X; Li R; Pan Y; Liu C; Yang T
    Biomed Chromatogr; 2024 Feb; 38(2):e5782. PubMed ID: 38016814
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Fuzheng Huayu recipe promotes the fenestration of capillarization in liver sinusoidal endothelial cells].
    Xie Z; Yu Y; Feng D; Xie J; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):723-8. PubMed ID: 26267683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
    Hu YY; Liu P; Liu C
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of Siniruangan Recipe on Proliferation, Apoptosis and Activation of Human Hepatic Stellate Cell Line LX-2.
    Liu J; Zhao G; Ai B; He Y; Mei M; Zou J; Xiao B; Yin Z
    Pharmacology; 2019; 104(5-6):342-351. PubMed ID: 31390636
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.
    Yang T; Zheng TH; Zhao Q; Liu W; Li SP; Tao YY; Wang CH; Liu CH
    Pharm Biol; 2020 Dec; 58(1):1-7. PubMed ID: 31847670
    [No Abstract]   [Full Text] [Related]  

  • 72. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
    Li J; Jia M; Liu Y; She W; Li L; Wang J; Jiang W
    Liver Int; 2015 Mar; 35(3):834-45. PubMed ID: 24814578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells.
    Feng G; Zhang JY; Zeng QL; Yu X; Zhang Z; Lv S; Xu X; Wang FS
    Hepatol Res; 2014 Oct; 44(10):E198-205. PubMed ID: 23905760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.
    Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Zhou RX; He J; Tang BZ
    World J Gastroenterol; 2005 May; 11(19):2892-9. PubMed ID: 15902724
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Yu Jin Pulvis inhibits carbon tetrachloride-induced liver fibrosis by blocking the MAPK and PI3K/Akt signaling pathways.
    Wu W; Piao H; Wu F; Han Y; An D; Wu Y; Lin Z; Piao Y; Jin J
    Am J Transl Res; 2019; 11(9):5998-6006. PubMed ID: 31632567
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.
    Xu L; Hui AY; Albanis E; Arthur MJ; O'Byrne SM; Blaner WS; Mukherjee P; Friedman SL; Eng FJ
    Gut; 2005 Jan; 54(1):142-51. PubMed ID: 15591520
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effects of Chinese herbal medicine Fuzheng Huayu recipe and its components against hepatocyte apoptosis in mice with hepatic injury].
    Zhou T; Yan XC; Chen Q; Tao YY; Hu YY; Liu P; Liu CH
    Zhong Xi Yi Jie He Xue Bao; 2011 Jan; 9(1):57-63. PubMed ID: 21227034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
    Horani A; Muhanna N; Pappo O; Melhem A; Alvarez CE; Doron S; Wehbi W; Dimitrios K; Friedman SL; Safadi R
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G628-38. PubMed ID: 17038628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.